A novel high‐performance liquid chromatography with diode array detector method for the simultaneous quantification of the enzyme‐reactivating oximes obidoxime, pralidoxime, and HI‐6 in human plasma
Authors:
Open Access
- 8 April 2020
- journal article
- research article
- Published by Wiley in Drug Testing and Analysis
- Vol. 12 (7) , 938-947
Abstract
Oximes such as pralidoxime (2‐PAM), obidoxime (Obi), and HI‐6 are the only currently available therapeutic agents to reactivate inhibited acetylcholinesterase (AChE) in case of intoxications with organophosphorus (OP) compounds. However, each oxime has characteristic agent‐dependent reactivating efficacy, and therefore the combined administration of complementary oximes might be a promising approach to improve therapy. Accordingly, a new high‐performance liquid chromatography method with diode‐array detection (HPLC‐DAD) was developed and validated allowing for simultaneous or single quantification of 2‐PAM, Obi, and HI‐6 in human plasma. Plasma was precipitated using 5% w/v aqueous zinc sulfate solution and subsequently acetonitrile yielding high recoveries of 94.2%–101.0%. An Atlantis T3 column (150 × 2.1mm I.D., 3 μm) was used for chromatographic separation with a total run time of 15 min. Quantification was possible without interferences within a linear range from 0.12 to 120 μg/mL for all oximes. Excellent intra‐day (accuracy 91.7%–98.6%, precision 0.5%–4.4%) and inter‐day characteristics (accuracy 89.4%–97.4%, precision 0.4%–2.2%) as well as good ruggedness were found. Oximes in processed samples were stable for at least 12 h in the autosampler at 15°C as well as in human plasma for at least four freeze–thaw cycles. Finally, the method was applied to plasma samples of a clinical case of pesticide poisoning.Keywords
This publication has 53 references indexed in Scilit:
- Purity of antidotal oxime HI‐6 DMS as an active pharmaceutical ingredient for auto‐injectors and infusionsDrug Testing and Analysis, 2012
- Quantification of pralidoxime (2‐PAM) in urine by ion pair chromatography‐diode array detection: application to in vivo samples from minipigDrug Testing and Analysis, 2011
- Review of UV spectroscopic, chromatographic, and electrophoretic methods for the cholinesterase reactivating antidote pralidoxime (2‐PAM)Drug Testing and Analysis, 2011
- Pharmacokinetics of obidoxime in patients poisoned with organophosphorus compoundsToxicology Letters, 2010
- Management of acute organophosphorus pesticide poisoningThe Lancet, 2008
- The global distribution of fatal pesticide self-poisoning: Systematic reviewBMC Public Health, 2007
- Atropine Absorption after Intramuscular Administration with 2-Pralidoxime Chloride by Two Automatic Injector DevicesJournal of Pharmaceutical Sciences, 1989
- Pharmacokinetics of pralidoxime chloride in the ratLife Sciences, 1986
- The chemical basis of the “ageing process” of DFP-inhibited pseudocholinesteraseBiochimica et Biophysica Acta, 1959
- A powerful reactivator of alkylphosphate-inhibited acetylcholinesteraseBiochimica et Biophysica Acta, 1955